ibn-iw-globe-2.png
REE International Appoints Paul Rutter to Advisory Board
November 09, 2011 16:05 ET | REE International, Inc.
BOSTON, MA--(Marketwire - Nov 9, 2011) - REE International, Inc. (PINKSHEETS: REEI) (the "Company"), a U.S. based mineral exploration company focused on the exploration and production of rare earth...
ibn-iw-globe-2.png
REE International Announces Appointment of Veteran Geologist Jose Padilla to Advisory Board
November 02, 2011 16:05 ET | REE International, Inc.
BOSTON, MA--(Marketwire - Nov 2, 2011) - REE International, Inc. (PINKSHEETS: REEI) (the "Company"), a U.S. based mineral exploration company focused on the exploration and production of rare earth...
ibn-iw-globe-2.png
VistaGen Therapeutics Reports Identification of Cell Surface Marker That Permits High-Yield Purification of Human Pluripotent Stem Cell-Derived Cardiomyocytes
October 25, 2011 09:30 ET | VistaGen Therapeutics, Inc.
SOUTH SAN FRANCISCO, CA--(Marketwire - Oct 25, 2011) - VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company applying stem cell technology for drug rescue and cell therapy, announces...
ibn-iw-globe-2.png
REE International CEO Issues Letter to Shareholders
October 18, 2011 08:17 ET | REE International, Inc.
BOSTON, MA--(Marketwire - Oct 18, 2011) - REE International, Inc. (PINKSHEETS: REEI) (the "Company") today provides the following letter to the investment community from its CEO Tom Mackay. ...
ibn-iw-globe-2.png
REE International Appoints Tom Mackay as Chief Executive Officer
October 17, 2011 13:42 ET | REE International, Inc.
BOSTON, MA--(Marketwire - Oct 17, 2011) - REE International, Inc. (PINKSHEETS: REEI) (the "Company") announces today that Tom Mackay has been named CEO, effective immediately. Mr. Mackay joins the...
ibn-iw-globe-2.png
Newport Digital Technologies Announces Restructuring Plan
October 17, 2011 06:00 ET | Newport Digital Technologies, Inc.
NEWPORT BEACH, CA--(Marketwire - Oct 17, 2011) - Newport Digital Technologies, Inc. (OTCBB: NPDT) (OTCQB: NPDT) today announces a comprehensive restructuring plan that includes seeking shareholder...
ibn-iw-globe-2.png
VistaGen Therapeutics Presents Highlights of Its Human Stem Cell-Derived "Micro-Heart" Cardiotoxicity Assay at NIH Symposium on Cardiovascular Regenerative Medicine
October 05, 2011 09:30 ET | VistaGen Therapeutics, Inc.
SOUTH SAN FRANCISCO, CA--(Marketwire - Oct 5, 2011) - VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company applying stem cell technology for drug rescue and cell therapy, announces a...
ibn-iw-globe-2.png
VistaGen Therapeutics Expands Key Stem Cell Technology Patent Estate Supporting Its Drug Rescue and Cell Therapy Programs
September 28, 2011 09:30 ET | VistaGen Therapeutics, Inc.
SOUTH SAN FRANCISCO, CA--(Marketwire - Sep 28, 2011) - VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company applying stem cell technology for drug rescue and cell therapy, announces...
ibn-iw-globe-2.png
VistaGen Therapeutics Reports Advances in Its Pancreatic Cell and Regenerative Medicine Programs
September 26, 2011 09:00 ET | VistaGen Therapeutics, Inc.
SOUTH SAN FRANCISCO, CA--(Marketwire - Sep 26, 2011) - VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company applying stem cell technology for drug rescue and cell therapy, announces...
ibn-iw-globe-2.png
VistaGen Therapeutics Provides Investor Update on Corporate Activities and Upcoming Initiatives
September 14, 2011 09:29 ET | VistaGen Therapeutics, Inc.
SOUTH SAN FRANCISCO, CA--(Marketwire - Sep 14, 2011) - VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company primarily focused on applying stem cell technology for drug rescue and cell...